Tower Research Capital LLC (TRC) - TREACE MED CONCEPTS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$53,501
+17.2%
4,081
+128.6%
0.00%0.0%
Q2 2023$45,660
+175515.4%
1,785
+72.8%
0.00%
+100.0%
Q1 2023$26
-72.3%
1,033
-74.5%
0.00%
-75.0%
Q4 2022$94
-99.9%
4,053
-24.4%
0.00%
+100.0%
Q3 2022$118,000
+107.0%
5,363
+35.2%
0.00%
+100.0%
Q2 2022$57,000
+111.1%
3,966
+181.7%
0.00%
Q1 2022$27,000
+92.9%
1,408
+88.7%
0.00%
Q4 2021$14,000
+55.6%
746
+124.0%
0.00%
Q3 2021$9,000
+200.0%
333
+278.4%
0.00%
Q2 2021$3,000880.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 1,907,823$25,011,5602.31%
FORMULA GROWTH LTD 222,269$2,913,9470.99%
EMERALD MUTUAL FUND ADVISERS TRUST 1,193,939$15,652,5400.94%
EMERALD ADVISERS, LLC 1,473,281$19,314,7130.94%
Perceptive Advisors 1,834,060$24,044,5270.80%
NEXT CENTURY GROWTH INVESTORS LLC 512,738$6,721,9950.73%
OBERWEIS ASSET MANAGEMENT INC/ 355,600$4,661,9160.50%
Novo Holdings A/S 360,000$4,719,6000.35%
TimesSquare Capital Management, LLC 1,433,429$18,7920.29%
KORNITZER CAPITAL MANAGEMENT INC /KS 677,733$8,885,0800.18%
View complete list of TREACE MED CONCEPTS INC shareholders